Poseida Therapeutics, Inc. Accumulated Other Comprehensive Income
Poseida Therapeutics, Inc. had Accumulated Other Comprehensive Income of $376.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-11-07
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $376.00K.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$82.00K.
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$47.00K.
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $126.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2024-09-30 | $376.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$82.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | -$47.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $126.00K 10-Q · filed 2024-11-07 |
| 2023-09-30 | -$200.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$280.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$149.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | -$144.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$132.00K 10-Q · filed 2022-08-11 |
| 2021-06-30 | $1.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $15.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $5.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | -$39.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $20.00K 10-Q · filed 2020-08-20 |
| 2019-12-31 | $19.00K 10-K · filed 2021-03-11 |